We report the case of a 54-year-old, quadriplegic woman with a methicillin-resistant Staphylococcus aureus (MRSA) vaginal infection. After failing a five-day course of intravenous vancomycin therapy, the patient was treated for ten days with mupirocin ointment applied intravaginally twice daily, which resulted in eradication of the infection. This report details a novel approach in treating MRSA vaginal infections.
Get full access to this article
View all access options for this article.
References
1.
JevonsMP. “Celbenin”-resistant staphylococci. Br Med J1961; 1: 124–5.
2.
BarrettFFMcGheeRFJrFinlandM. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med1968; 279: 441–8.
3.
BaconAEJorgensenKAWilsonKHKauffmanCA. Emergence of nosocomial methicillin resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control Hosp Epidemiol1987; 8: 145–50.
4.
StorchGARadcliffJLMeyerPLHinrichsJH. Methicillin-resistant Staphylococcus aureus in a nursing home. Infect Control Hosp Epidemiol1987; 8: 24–9.
5.
SutherlandRBoonRJGriffinKEMastersPJSlocombeBWhiteAR. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother1985; 27: 495–8.
6.
WhiteARBealeASBoonRJGriffinKEMastersPJSutherlandR. Antibacterial activity of mupirocin, an antibiotic produced by Pseudomonas fluorescens. In: WilkinsonDSPriceJD, eds. Mupirocin—a novel topical antibiotic. London: Royal Society of Medicine, 1984: 43–55.
7.
Mupirocin. In: McEvoyGK, ed. American hospital formulary service drug information 91. Bethesda, MD: American Society of Hospital Pharmacists, 1991: 2081–3.
8.
WardACampoli-RichardsDM. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs1986; 32: 425–44.
9.
KobayashiHTsuzukiMHosobuchiK. Brief report: Bactericidal effects of antiseptics and disinfectants against methicillin-resistantStaphylococcus aureus. Infect Control Hosp Epidemiol1989; 10: 562–4.
10.
CasewellMWHillRLR. Elimination of nasal carriage of Staphylococcus aureus with mupirocin (pseudomonic acid)—a controlled trial. J Antimicrob Chemother1986; 17: 365–72.
11.
DenningDWHaiduven-GriffithsD. Eradication of low level methicillin-resistant Staphylococcus aureus skin colonization with topical mupirocin. Infect Control Hosp Epidemiol1988; 9: 261–3.
